Table of Contents Author Guidelines Submit a Manuscript
Clinical and Developmental Immunology
Volume 12, Issue 3, Pages 197-202
http://dx.doi.org/10.1080/17402520500233510

The Diagnostic Utility of Anti-cyclic Citrullinated Peptide Antibodies, Matrix Metalloproteinase-3, Rheumatoid Factor, Erythrocyte Sedimentation Rate, and C-reactive Protein in Patients with Erosive and Non-erosive Rheumatoid Arthritis

1Center for Autoimmune Diseases, Department of Medicine ‘B’, Sheba Medical Center, Israel
2Department of Medicine ‘B’ Wolfson Medical Center, Sackler Faculty of Medicine, Tel-Aviv University, Holon, Israel
3Dipartmrnt Di Medicina Clinica e Sperimentale, Universita Di Perugia, Sezione di Medicina Interna e Scienze Oncologiche Policlinico Monteluco, Perugia, Italy
4Incumbent of the Laura Schwarz-Kipp Chair for Research of Autoimmune Diseases, Tel-Aviv University, Tel-Hashomer, Israel

Copyright © 2005 Hindawi Publishing Corporation. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

How to Cite this Article

O. Shovman, B. Gilburd, G. Zandman-Goddard, et al., “The Diagnostic Utility of Anti-cyclic Citrullinated Peptide Antibodies, Matrix Metalloproteinase-3, Rheumatoid Factor, Erythrocyte Sedimentation Rate, and C-reactive Protein in Patients with Erosive and Non-erosive Rheumatoid Arthritis,” Clinical and Developmental Immunology, vol. 12, no. 3, pp. 197-202, 2005. https://doi.org/10.1080/17402520500233510.